New Delhi: Serum Institute of India’s trial for ‘Covishield’ vaccine developed by the University of Oxford started on Tuesday, with the first patients screened by Bharati Vidyapeeth Deemed University (BVDU) Medical College and Hospital in Pune.“Today, we have screened some patients.
Tomorrow, we will get their covid antibody test reports, and if they come negative, we will inoculate with the ‘Covishield’ vaccine," Sanjay Lalwani, principal investigator for the hospital told Mint, adding that the hospital aims to have about 300-350 participants as part of the trial.Indian Council of Medical Research director general Balram Bhargava on Tuesday confirmed that the trials for the ‘Covishield’ vaccine, jointly developed by the University of.